| 1 | remains | 15,122 |
| 2 | -n-methyl-22,26-epiminocholest-3 | 1 |
| 3 | cataplexy.in | 1 |
| 4 | development.2 | 1 |
| 5 | outbalance | 1 |
| 6 | settings.participants | 1 |
| 7 | survivors-had | 1 |
| 1 | -n-methyl-22,26-epiminocholest-3 | 1 |
| 2 | cataplexy.in | 1 |
| 3 | development.2 | 1 |
| 4 | outbalance | 1 |
| 5 | remains | 15,122 |
| 6 | settings.participants | 1 |
| 7 | survivors-had | 1 |
| 1 | development.2 | 1 |
| 2 | -n-methyl-22,26-epiminocholest-3 | 1 |
| 3 | survivors-had | 1 |
| 4 | outbalance | 1 |
| 5 | cataplexy.in | 1 |
| 6 | remains | 15,122 |
| 7 | settings.participants | 1 |